Supriya Lifescience Ltd
BSE:543434
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Supriya Lifescience Ltd
BSE:543434
|
IN |
|
D
|
Ducommun Inc
XBER:DUM
|
US |
|
Semiconductor Manufacturing International Corp
HKEX:981
|
CN |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
DUS:MUV2
|
DE |
|
R
|
Renishaw PLC
SWB:REW
|
UK |
|
Danske Bank A/S
F:DSN0
|
DK |
|
T
|
Telenor ASA
XBER:TEQ
|
NO |
|
C
|
CCL Industries Inc
OTC:CCLLF
|
CA |
|
E
|
Edgewell Personal Care Co
F:EGZ
|
US |
|
Quantum Graphite Ltd
OTC:VLQCF
|
AU |
Wall St Price Targets
SUPRIYA Price Targets Summary
Supriya Lifescience Ltd
According to Wall Street analysts, the average 1-year price target for SUPRIYA is 864.54 INR with a low forecast of 856.07 INR and a high forecast of 889.97 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SUPRIYA's stock price target?
Price Target
864.54
INR
According to Wall Street analysts, the average 1-year price target for SUPRIYA is 864.54 INR with a low forecast of 856.07 INR and a high forecast of 889.97 INR.
What is the Revenue forecast for Supriya Lifescience Ltd?
Projected CAGR
27%
Over the last 7 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 2 years is 27%.
What is the Gross Profit forecast for Supriya Lifescience Ltd?
Projected CAGR
30%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 25%. The projected CAGR for the next 2 years is 30%.
What is the Operating Income forecast for Supriya Lifescience Ltd?
Projected CAGR
29%
Over the last 7 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 2 years is 29%.
What is the Pre-Tax Income forecast for Supriya Lifescience Ltd?
Projected CAGR
29%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 25%. The projected CAGR for the next 2 years is 29%.
What is the Net Income forecast for Supriya Lifescience Ltd?
Projected CAGR
27%
Over the last 7 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 2 years is 27%.
